{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T07:45:26Z","timestamp":1783755926515,"version":"3.55.0"},"reference-count":33,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.3201\/eid2106.141480","type":"journal-article","created":{"date-parts":[[2015,4,29]],"date-time":"2015-04-29T12:28:42Z","timestamp":1430310522000},"source":"Crossref","is-referenced-by-count":55,"title":["Consensus on the Development of Vaccines against Naturally Acquired Melioidosis"],"prefix":"10.3201","volume":"21","author":[{"given":"Direk","family":"Limmathurotsakul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon G.P.","family":"Funnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo G.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"Morici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Brett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Dunachie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Atkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel M.","family":"Altmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Bancroft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon J.","family":"Peacock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for The Steering Group on Melioidosis Vaccine Development","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid2106.141480-201504290835-R1","unstructured":"Centers for Disease Control and Prevention. Bioterrorism agents\/diseases [cited 2014 Jul 14] http:\/\/www.bt.cdc.gov\/agent\/agentlist-category.asp"},{"key":"key-10.3201\/eid2106.141480-201504290835-R2","unstructured":"National Select Agent Registry. HHS and USDA select agents and toxins. 7 CFR Part 331, 9 CFR Part 121, and 42 CFR Part 73 [cited 2014 Jul 14]. http:\/\/www.selectagents.gov\/Select%20Agents%20and%20Toxins%20Exclusions.html"},{"key":"key-10.3201\/eid2106.141480-201504290835-R3","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1056\/NEJMra1204699","article-title":"Melioidosis.","volume":"367","author":"Wiersinga","year":"2012","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2106.141480-201504290835-R4","first-page":"\u2022\u2022\u2022","article-title":"Melioidosis diagnostic workshop, 2013.","volume":"21","author":"Hoffmaster","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2106.141480-201504290835-R5","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.3201\/eid1812.120638","article-title":"Workshop on treatment of and postexposure prophylaxis for Burkholderia pseudomallei and B. mallei Infection, 2010.","volume":"18","author":"Lipsitz","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2106.141480-201504290835-R6","doi-asserted-by":"publisher","first-page":"e2105","DOI":"10.1371\/journal.pntd.0002105","article-title":"Systematic review and consensus guidelines for environmental sampling of Burkholderia pseudomallei.","volume":"7","author":"Limmathurotsakul","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"key-10.3201\/eid2106.141480-201504290835-R7","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.4269\/ajtmh.2010.10-0038","article-title":"Increasing incidence of human melioidosis in Northeast Thailand.","volume":"82","author":"Limmathurotsakul","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"key-10.3201\/eid2106.141480-201504290835-R8","doi-asserted-by":"publisher","first-page":"e1488","DOI":"10.1371\/journal.pntd.0001488","article-title":"Melioidosis vaccines: a systematic review and appraisal of the potential to exploit biodefense vaccines for public health purposes.","volume":"6","author":"Peacock","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"key-10.3201\/eid2106.141480-201504290835-R9","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/j.clinthera.2010.07.020","article-title":"Progress toward development of vaccines against melioidosis: a review.","volume":"32","author":"Sarkar-Tyson","year":"2010","journal-title":"Clin Ther"},{"key":"key-10.3201\/eid2106.141480-201504290835-R10","doi-asserted-by":"crossref","unstructured":"Patel N, Conejero L, De Reynal M, Easton A, Bancroft GJ, Titball RW. Development of vaccines againstBurkholderia pseudomallei.Frontiers in microbiology. 2011;2:198.","DOI":"10.3389\/fmicb.2011.00198"},{"key":"key-10.3201\/eid2106.141480-201504290835-R11","doi-asserted-by":"crossref","unstructured":"Van Zandt KE, Tuanyok A, Keim PS, Warren RL, Gelhaus HC. An objective approach forBurkholderia pseudomalleistrain selection as challenge material for medical countermeasures efficacy testing. Frontiers in cellular and infection microbiology. 2012;2:120.","DOI":"10.3389\/fcimb.2012.00120"},{"key":"key-10.3201\/eid2106.141480-201504290835-R12","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1016\/S1472-9792(12)70009-4","article-title":"Rational approach to selection and clinical development of TB vaccine candidates.","volume":"92","author":"Barker","year":"2012","journal-title":"Tuberculosis (Edinb)"},{"key":"key-10.3201\/eid2106.141480-201504290835-R13","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1128\/IAI.70.2.504-511.2002","article-title":"Model of differential susceptibility to mucosal Burkholderia pseudomallei infection.","volume":"70","author":"Liu","year":"2002","journal-title":"Infect Immun"},{"key":"key-10.3201\/eid2106.141480-201504290835-R14","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1006\/mpat.1997.0179","article-title":"BALB\/c and C57Bl\/6 mice infected with virulent Burkholderia pseudomallei provide contrasting animal models for the acute and chronic forms of human melioidosis.","volume":"24","author":"Leakey","year":"1998","journal-title":"Microb Pathog"},{"key":"key-10.3201\/eid2106.141480-201504290835-R15","doi-asserted-by":"publisher","first-page":"5290","DOI":"10.1128\/IAI.70.9.5290-5294.2002","article-title":"A mutant of Burkholderia pseudomallei, auxotrophic in the branched chain amino acid biosynthetic pathway, is attenuated and protective in a murine model of melioidosis.","volume":"70","author":"Atkins","year":"2002","journal-title":"Infect Immun"},{"key":"key-10.3201\/eid2106.141480-201504290835-R16","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1086\/508217","article-title":"A live experimental vaccine against Burkholderia pseudomallei elicits CD4+ T cell-mediated immunity, priming T cells specific for 2 type III secretion system proteins.","volume":"194","author":"Haque","year":"2006","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2106.141480-201504290835-R17","doi-asserted-by":"publisher","first-page":"S111","DOI":"10.1016\/S0035-9203(08)70026-9","article-title":"Burkholderia pseudomallei: animal models of infection.","volume":"102","author":"Titball","year":"2008","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"key-10.3201\/eid2106.141480-201504290835-R18","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1099\/jmm.0.45766-0","article-title":"Evaluation of lipopolysaccharide and capsular polysaccharide as subunit vaccines against experimental melioidosis.","volume":"53","author":"Nelson","year":"2004","journal-title":"J Med Microbiol"},{"key":"key-10.3201\/eid2106.141480-201504290835-R19","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1128\/JB.186.8.2288-2294.2004","article-title":"The PmlI-PmlR quorum-sensing system in Burkholderia pseudomallei plays a key role in virulence and modulates production of the MprA protease.","volume":"186","author":"Valade","year":"2004","journal-title":"J Bacteriol"},{"key":"key-10.3201\/eid2106.141480-201504290835-R20","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.micinf.2011.07.008","article-title":"Altered macrophage function is associated with severe Burkholderia pseudomallei infection in a murine model of type 2 diabetes.","volume":"13","author":"Hodgson","year":"2011","journal-title":"Microbes Infect"},{"key":"key-10.3201\/eid2106.141480-201504290835-R21","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1128\/IAI.00930-12","article-title":"Impaired early cytokine responses at the site of infection in a murine model of type 2 diabetes and melioidosis comorbidity.","volume":"81","author":"Hodgson","year":"2013","journal-title":"Infect Immun"},{"key":"key-10.3201\/eid2106.141480-201504290835-R22","first-page":"170","article-title":"Pathological changes in goats experimentally inoculated with Pseudomonas pseudomallei.","volume":"22","author":"Narita","year":"1982","journal-title":"Natl Inst Anim Health Q (Tokyo)"},{"key":"key-10.3201\/eid2106.141480-201504290835-R23","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/iep.12105","article-title":"Comparative experimental subcutaneous glanders and melioidosis in the common marmoset (Callithrix jacchus).","volume":"95","author":"Nelson","year":"2014","journal-title":"Int J Exp Pathol"},{"key":"key-10.3201\/eid2106.141480-201504290835-R24","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1128\/IAI.64.7.2824-2828.1996","article-title":"Structural and immunological characterization of Burkholderia pseudomallei O-polysaccharide-flagellin protein conjugates.","volume":"64","author":"Brett","year":"1996","journal-title":"Infect Immun"},{"key":"key-10.3201\/eid2106.141480-201504290835-R25","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1152\/physiol.00049.2004","article-title":"Transgenic and knockout mice in diabetes research: novel insights into pathophysiology, limitations, and perspectives.","volume":"20","author":"Plum","year":"2005","journal-title":"Physiology (Bethesda)"},{"key":"key-10.3201\/eid2106.141480-201504290835-R26","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1099\/jmm.0.059063-0","article-title":"Pathological findings and diagnostic implications of a rhesus macaque (Macaca mulatta) model of aerosol-exposure melioidosis (Burkholderia pseudomallei).","volume":"63","author":"Yingst","year":"2014","journal-title":"J Med Microbiol"},{"key":"key-10.3201\/eid2106.141480-201504290835-R27","doi-asserted-by":"publisher","first-page":"3332","DOI":"10.1128\/IAI.00675-12","article-title":"Natural history of inhalation melioidosis in rhesus macaques (Macaca mulatta) and African green monkeys (Chlorocebus aethiops).","volume":"80","author":"Yeager","year":"2012","journal-title":"Infect Immun"},{"key":"key-10.3201\/eid2106.141480-201504290835-R28","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1017\/S095026889700825X","article-title":"Effectiveness of influenza vaccine in reducing hospital admissions in people with diabetes.","volume":"119","author":"Colquhoun","year":"1997","journal-title":"Epidemiol Infect"},{"key":"key-10.3201\/eid2106.141480-201504290835-R29","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/(SICI)1096-9136(199607)13:7<630::AID-DIA137>3.0.CO;2-7","article-title":"Successful immune response to a recombinant hepatitis B vaccine in young patients with insulin-dependent diabetes mellitus.","volume":"13","author":"Marseglia","year":"1996","journal-title":"Diabet Med"},{"key":"key-10.3201\/eid2106.141480-201504290835-R30","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.1016\/j.vaccine.2013.05.003","article-title":"Young and elderly patients with type 2 diabetes have optimal B cell responses to the seasonal influenza vaccine.","volume":"31","author":"Frasca","year":"2013","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2106.141480-201504290835-R31","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2337\/diacare.23.1.95","article-title":"Use of influenza and pneumococcal vaccines in people with diabetes.","volume":"23","author":"Smith","year":"2000","journal-title":"Diabetes Care"},{"key":"key-10.3201\/eid2106.141480-201504290835-R32","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1001\/jama.1997.03550160053038","article-title":"Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people.","volume":"278","author":"Sisk","year":"1997","journal-title":"JAMA"},{"key":"key-10.3201\/eid2106.141480-201504290835-R33","doi-asserted-by":"crossref","unstructured":"Kesavadev J, Misra A, Das AK, Saboo B, Basu D, Thomas N, Suggested use of vaccines in diabetes. Indian J Endocrinol Metab. 2012;16:886\u201393.","DOI":"10.4103\/2230-8210.102982"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/21\/6\/14-1480_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T23:21:19Z","timestamp":1732922479000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/21\/6\/14-1480_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"URL":"https:\/\/doi.org\/10.3201\/eid2106.141480","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6]]}}}